A recent study indicated that exosomes carrying lncRNA prostate androgen-regulated transcript 1 (PART1) derived from Gefitinib-resistant cells confer cisplatin resistance in ESCC (69). The gene discussed is PART1; the disease is esophageal squamous cell carcinoma.